Advertisement

Topics

Evoke Pharma, Inc. Company Profile

18:54 EST 20th November 2018 | BioPortfolio

Evoke Pharma, Inc. is a privately held, specialty pharmaceutical company headquartered in San Diego, CA focused on acquiring and developing products to treat GI disorders and diseases. Evoke's lead product, EVK-001, is currently in Phase 2b for the treatment of the symptoms associated with diabetic gastroparesis. The management team has an established track record of building successful specialty pharmaceutical companies. The company completed a $12 million Series A financing from Domain Associates and Latterell Venture Partners. Evoke holds rights to intellectual property associated with EVK-001 granted by the United States Patent & Trademark Office with expiration dates through 2021.


News Articles [525 Associated News Articles listed on BioPortfolio]

Evoke Pharma’s Gimoti NDA Accepted for FDA Review

Evoke Pharma (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company’s 505(b)(2) New Drug Application (NDA) for G...

Small-Cap Snapshot: Evoke Pharma is on the rise after US regulators say they will review its drug Gimoti

Small cap names on the move today are: Evoke Pharma Inc (NASDAQ:EVOK), Ferroglobe PLC (NASDAQ:GSM), Pain Therapeutics Inc (NASDAQ:PTIE), JC Penney Inc (NYSE:JCP). 

Evoke Announces FDA Submission of New Drug Application for Gimoti

SOLANA BEACH, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced t...

ARAY Reports Record Revenue, PTIE Bleeds, EVOK To Face FDA In April

Today's Daily Dose brings you news about Accuray's financial results; stock offerings of AVEO and Pain Therapeutics; Evoke Pharma's upcoming regulatory catalyst in April and FDA approval for expanded ...

Evoke Group unveils new identity

Rebrands to help clients better navigate the healthcare landscape

Research drug may one day be novel treatment for systemic inflammatory response syndrome

When trauma spills the contents of our cell powerhouses, it can evoke a potentially deadly immune response much like a severe bacterial infection.

Specific neurons may cause male aggressiveness

Scientists have managed to identify certain neurons in the brain that could evoke sense of aggressiveness. This could mean that problems associated with aggression could not be understood better and p...

Evoke Pharma Inc EVOK Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryEvoke Pharma Inc Evoke Pharma is a specialty pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company's lead product candidate EVK001 is under clinical develop...

Drugs and Medications [241 Associated Drugs and Medications listed on BioPortfolio]

Evoke antiperspirant deodorant [PSS World Medical]

EVOKE Antiperspirant & Deodorant Spray

Evoke antiperspirant and deodorant roll-on [PSS World Medical]

EVOKE Antiperspirant & Deodorant Roll On

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

PubMed Articles [63 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

Disease awareness advertising (DAA) in emerging economy: A comparison between views of consumers and pharmaceutical professionals.

Research on effectiveness of DAA is limited. Existing researches explore impact of DAA only on relationship between drug manufacturers and consumers. However, in reality, pharma marketing revolves aro...

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

The Common Pharmaceutical Market of the Eurasian Economic Union: A Regulatory Review.

According to the Treaty on the Eurasian Economic Union, a common pharmaceutical market was supposed to become operational on January 1, 2016. Nevertheless, the responsible parties did not meet the dea...

Clinical Trials [109 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [778 Associated Companies listed on BioPortfolio]

Evoke Pharma, Inc.

Evoke Pharma, Inc. is a privately held, specialty pharmaceutical company headquartered in San Diego, CA focused on acquiring and developing products to treat GI disorders and diseases. Evoke's lead pr...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Alex Woo

Alex Woo is a jewelry designer based in New York whose work delicately balances the trendy "must have" and the classic into sleek and stylish designs that evoke the bold strength of today's women, whi...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

More Information about "Evoke Pharma, Inc." on BioPortfolio

We have published hundreds of Evoke Pharma, Inc. news stories on BioPortfolio along with dozens of Evoke Pharma, Inc. Clinical Trials and PubMed Articles about Evoke Pharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Evoke Pharma, Inc. Companies in our database. You can also find out about relevant Evoke Pharma, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...


Corporate Database Quicklinks



Searches Linking to this Company Record